Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Net Change in Cash

$1.42M

Quarterly · Period ending: · USD

LCTX logo

LCTX Net Change in Cash

Latest reported$1.42M
LCTX Quarterly Net Change in Cash (-$300.00K → $1.42M)
High-resolution chart · PNG

LCTX net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
-128,539
-996,826
-702,286
-406,252
-1,260,501
-1,605,429
-1,307,194
-600,000
-1,400,000
6,100,000
-800,000
-1,000,000
-7,400,000
-1,100,000
-400,000
500,000
5,500,000
-200,000
-400,000
-600,000
2,600,000
-600,000
1,200,000
-500,000
-500,000
-1,400,000
1,500,000
-300,000
-2,400,000
-300,000
-300,000
-400,000
-300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.